Eureka, California Becomes The 5th City In California To Decriminalize Psychedelics
The 10th annual Psychedelic Culture conference upheld its tradition of showing the psychedelic space, as well as the world at large, why it’s a can’t-miss event. Hosted by Chacruna, a distinguished legacy institute for psychedelic plant medicines and indigenous/cultural advocacy, the event took place in the Mission District of San Francisco April 17-19th culminating on Bicycle Day and Indigenous Peoples’ Day in Brazil.
Having attended the surprisingly few SoCal events over the past few years, it was such a welcome pleasure to see familiar faces coming together in LA for 3 days of meaningful conversations centered around healing, community, access, learning, and networking at Psychedelic Awakening 2025 hosted by Psychedelic Institute of Los Angeles.
For its fifth installment, Psychedelic Science 2025 returned to Denver, offering three days of big ideas, heartfelt community, and some noticeable shifts in the psychedelic space. After the usual chaos of delayed flights and travel drama on Tuesday, we shared a collective sigh of relief as we finally arrived at the Colorado Convention Center, a mile high and ready to dive in.
In this episode of the $Psyc Business Roundup, we’ll cover Algernon Pharmaceuticals (OTC: AGNPF, CSE: AGN) is planning to begin a clinical trial using DMT to treat acute strokes.
Conventional mental health therapies have offered little help. But a growing number of professional athletes are finding the path back to a better life with a more unconventional therapy—psychedelics. These five athletes are leading the way in psychedelic therapy.